121 related articles for article (PubMed ID: 5820666)
1. Structural requirements for binding of bradykinin to antibody. 3. The effect of carrier on antibody specificity.
Fischer J; Spragg J; Talamo RC; Pierce JV; Suzuki K; Austen KF; Haber E
Biochemistry; 1969 Sep; 8(9):3750-7. PubMed ID: 5820666
[No Abstract] [Full Text] [Related]
2. Structural requirements for binding of bradykinin to antibody. II. Studies with bradykinin fragments.
Spragg J; Talamo RC; Suzuki K; Appelbaum DM; Austen KF; Haber E
Biochemistry; 1968 Nov; 7(11):4086-9. PubMed ID: 5749176
[No Abstract] [Full Text] [Related]
3. Antibody to bradykinin: effect of carrier and method of coupling on specificity and affinity.
Talamo RC; Haber E; Austen KF
J Immunol; 1968 Aug; 101(2):333-41. PubMed ID: 4970069
[No Abstract] [Full Text] [Related]
4. Determination of human urinary kinin levels by radioimmunoassay using a tyrosine analogue of bradykinin.
Mashford ML; Roberts ML
Biochem Pharmacol; 1971 May; 20(5):969-73. PubMed ID: 5168394
[No Abstract] [Full Text] [Related]
5. Structural requirements for binding to antibody of sequence variants of bradykinin.
Spragg J; Schröder E; Stewart JM; Austen KF; Haber E
Biochemistry; 1967 Dec; 6(12):3933-41. PubMed ID: 5299782
[No Abstract] [Full Text] [Related]
6. The substrate recognition site of collagen proline hydroxylase: the hydroxylation of -X-Pro-Gly- sequences in bradykinin analogs and other peptides.
McGee JO; Rhoads RE; Udenfriend S
Arch Biochem Biophys; 1971 May; 144(1):343-51. PubMed ID: 5117532
[No Abstract] [Full Text] [Related]
7. A general method for the specific isolation of peptides containing modified residues, using insoluble antibody columns.
Wilchek M; Bocchini V; Becker M; Givol D
Biochemistry; 1971 Jul; 10(15):2828-34. PubMed ID: 5165492
[No Abstract] [Full Text] [Related]
8. The use of substituent constants in the quantitative treatment of hapten-antibody interaction.
Kutter E; Hansch C
Arch Biochem Biophys; 1969 Dec; 135(1):126-35. PubMed ID: 5391470
[No Abstract] [Full Text] [Related]
9. Neutralization by an antibody of some vascular actions of bradykinin.
Martin CA; Mashford ML; Roberts ML
Biochem Pharmacol; 1971 Nov; 20(11):3179-84. PubMed ID: 4108901
[No Abstract] [Full Text] [Related]
10. Modification of arginine in the active sites of antibodies.
Grossberg AL; Pressman D
Biochemistry; 1968 Jan; 7(1):272-9. PubMed ID: 4098210
[No Abstract] [Full Text] [Related]
11. Combining sites of IgG and IgM antibodies of poly-D-alanyl specificity.
Haimovich J; Schechter I; Sela M
Eur J Biochem; 1969 Feb; 7(4):537-43. PubMed ID: 5813322
[No Abstract] [Full Text] [Related]
12. Proof of independency of two antigenic sites in egg white lysozyme.
Fujio H; Imanishi M; Nishioka K; Amano T
Biken J; 1968 Sep; 11(3):219-23. PubMed ID: 5721303
[No Abstract] [Full Text] [Related]
13. Radioimmunoassay of bradykinin: chemical modification to enable use of radioactive iodine.
Goodfriend TL; Ball DL
J Lab Clin Med; 1969 Mar; 73(3):501-11. PubMed ID: 5766195
[No Abstract] [Full Text] [Related]
14. Relationship between chemical structure and antigenicity of angiotensin analogues.
Vallotton MB
Immunochemistry; 1970 Jun; 7(6):529-42. PubMed ID: 4320828
[No Abstract] [Full Text] [Related]
15. Aspects of bradykinin radioimmunoassay.
Odya CE; Goodfriend TL; Stewart JM; Peña C
J Immunol Methods; 1978; 19(2-3):243-57. PubMed ID: 624845
[TBL] [Abstract][Full Text] [Related]
16. Studies of the immunochemical specificity of some antibodies to human gastrin. I.
McGuigan JE
Gastroenterology; 1969 Mar; 56(3):429-38. PubMed ID: 5766901
[No Abstract] [Full Text] [Related]
17. The effects of epinephrine, amino acids and albumin on the measurement of insulin by radioimmunoassay.
Szabo O; Mahler RJ
Horm Metab Res; 1970 May; 2(3):125-30. PubMed ID: 5535405
[No Abstract] [Full Text] [Related]
18. Radioimmunoassay of human fibrinopeptide A.
Nossel HL; Younger LR; Wilner GD; Procupez T; Canfield RE; Butler VP
Proc Natl Acad Sci U S A; 1971 Oct; 68(10):2350-3. PubMed ID: 5289869
[TBL] [Abstract][Full Text] [Related]
19. The preparation and specificity of antibody to thyrotropin releasing hormone.
Bassiri RM; Utiger RD
Endocrinology; 1972 Mar; 90(3):722-7. PubMed ID: 4621569
[No Abstract] [Full Text] [Related]
20. Antivasopressin antibody. Characterization of high-affinity rabbit antibody with limited association constant heterogeneity.
Wu WH; Rockey JH
Biochemistry; 1969 Jul; 8(7):2719-28. PubMed ID: 5808330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
